An eco-friendly ultra-performance liquid chromatography-mass spectrometry method for quantification of rivaroxaban and ticagrelor in rat plasma: grapefruit interactions.
Marwa A MoffidEman A MostafaSally Tarek MahmoudRawda M SayedPublished in: Bioanalysis (2023)
Aim: An eco-friendly ultra-performance liquid chromatography-tandem mass spectrometry method was developed to study the pharmacokinetics of rivaroxaban and ticagrelor in rat plasma, utilizing moxifloxacin as an internal standard. The food-drug interaction between grapefruit juice and these drugs was also investigated. Methods: Liquid-liquid extraction was used. A nonporous stationary phase Agilent ® Poroshell 120EC C18 column was used with methanol: 0.1% aqueous formic acid (95:5 v/v) as a mobile phase. The detection was performed in multiple reaction monitoring mode using positive electrospray ionization. The method's validation was conducted in accordance with US FDA and European Medicines Agency guidelines. Results & conclusion: Grapefruit juice should be ingested with caution in patients treated with antithrombotic medications as it may increase their plasma concentration, inducing bleeding, and requires close clinical monitoring.
Keyphrases
- liquid chromatography
- mass spectrometry
- liquid chromatography tandem mass spectrometry
- simultaneous determination
- atrial fibrillation
- solid phase extraction
- high resolution mass spectrometry
- tandem mass spectrometry
- high resolution
- percutaneous coronary intervention
- acute coronary syndrome
- high performance liquid chromatography
- pulmonary embolism
- gas chromatography
- antiplatelet therapy
- st elevation myocardial infarction
- ms ms
- st segment elevation myocardial infarction
- risk assessment
- ionic liquid
- climate change
- adverse drug
- electron transfer
- single molecule